| Logo | Name | Σ | Employees |
|---|---|---|---|
 |  UPSIDE Foods At UPSIDE Foods (formerly known as Memphis Meats), we're making your favorite food a force for good. Meat made from cells. We’re building the future you’re hungry for. *all meat shown is UPSIDE meat https://linktr.ee/upsidefoods Cultivated meat is new to many of us, and here at UPSIDE, we encourage education, learning, and fact-based debate. We ask that, in accordance with our values, you keep the conversation respectful to each other and to us. Thanks! cell culture, cultured meat, food science, food tech, meat, food, research and development, biology, process development, cell-based meat, and cultured meat 7 similar entities Type: Startup Activities: agritech biotech deeptech foodtech manufacturing Technologies: Synthetic Biology | 16 | 247 |
 | Suvoda IRT, eConsent, eCOA, and ePatient solutions to help you wisely guide novel science through complex clinical trials Suvoda is a global clinical trial technology company specializing in complex, life-sustaining studies in therapeutic areas like oncology, central nervous system (CNS), and rare diseases. Suvoda empowers sponsors, sites, and patients to manage the most urgent moments in the most urgent trials through advanced IRT, eConsent, eCOA, and ePatient software solutions delivered on a single platform. Clinical trial management, Interactive response technology, Subject randomization, Trial supply management, IWRS, IRT, Interactive Web Response System, Clinical Supplies, Patient Logistics, Clinical Supply Logistics, eCOA, ePatient, Clinical … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 10 | 1,013 |
 | Ryvu Therapeutics Developing novel treatments at the forefront of oncology Ryvu Therapeutics is a clinical-stage drug discovery and development company focused on novel small molecule therapies that address emerging targets in oncology. Internally discovered pipeline candidates make use of diverse therapeutic mechanisms driven by emerging knowledge of cancer biology, including small molecules directed at kinase, synthetic lethality, and immuno-oncology targets. Ryvu’s most advanced programs are RVU120 - a selective CDK8/CDK19 kinase inhibitor with potential for the treatment of hematological malignancies and solid tumors currently in Phase I clinical development for the treatment of acute myeloid leukemia and myelodysplastic syndrome, and Phase I/II … 5 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 277 |
 | Serna Bio Mapping the druggable transcriptome An estimated 85% of the ~3 billion base pairs in the human genome is transcribed into RNA, but only ~1.5% of these code for proteins. While the chemical properties of protein binders are increasingly understood and interrogated, the field of RNA-targeted drugs is relatively new and the properties of small molecules that drive specific and selective targeting of RNA, and associated assays, are yet to be developed. At Serna Bio [previously Ladder Therapeutics] we are using an AI enabled, data-first approach to write the rules that define RNA-small molecule interactions. Our Discovery Platform powers our first-in-class … 15 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology | 0 | 15 |
 | Foghorn Therapeutics Inc. Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Our proprietary Gene Traffic Control® platform gives us an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing us to identify, validate and potentially drug targets within the system. 70 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 128 |
 |  Sio Gene Therapies Pushing the boundaries of gene therapy to develop treatments for debilitating neurodegenerative diseases. Sio Gene Therapies combines cutting-edge science with bold imagination to develop genetic medicines that aim to radically improve the lives of patients. Our current pipeline of clinical-stage candidates includes the first potentially curative AAV-based gene therapies for GM1 gangliosidosis and Tay-Sachs/Sandhoff diseases, which are rare and uniformly fatal pediatric conditions caused by single gene deficiencies. We are also expanding the reach of gene therapy to highly prevalent conditions such as Parkinson’s disease, which affects millions of patients globally. Led by an experienced team of gene therapy development … 32 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 29 |
 | BGene Genetics Believe in Nature, belong to Future BGene aims at developing sustainable and resilient production ways for high value added, biobased molecules. To this end, BGene develops expertise in domains such as molecular biology, microbiology, biochemistry, process engineering and computer sciences. Food and feed, pharma, cosmetics, chemistry, and environment are among the diverse markets that BGene can address thanks to the cutting-edge bioprocesses developed by BGene know-how. Strain engineering, Microorganism chromosome engineering, Synthetic Biology, Molecular Biology, Bioinformatics, Bioprocess, and Enzyme Engineering 69 similar entities Type: Startup Activities: biotech deeptech Technologies: Bio sourced materials Synthetic Biology | 13 | 19 |
 | Gene&GreenTK Enzymes for agricultural transition Gene&GreenTK (GGTK) is a biotech company created in 2013 and incubated in the IHU of Marseille. The work of GGTK is dedicated to the development and engineering of innovative enzymes isolated from microorganisms living in extreme environments. Enzymes developed by GGTK have two main applications: - Anti-virulence and anti-biofilm for the development of sustainable alternative to conventional antimicrobial agents targeting applications in agriculture, animal nutrition or anti-fouling. - Bioremediation of organophosphorus chemicals for the degradation of insecticides and chemical warfare agents. enzyme, protein engineering, Quorum quenching, organophosphorus decontamination, bioremediation, anti-fouling, biofilm, bacterial virulence, biocatalysis, extremophiles, lactonase, … 2 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 5 | 10 |
 | INDIENOV Protecting the autonomy of vulnerable people. INDIENOV is a brand of HIPPY SAS, a company with a mission created in 2020 in France, whose “raison d'être” is “to contribute to the independence and promote the autonomy of people at risk by innovating in every way possible”. In France, more than 450,000 people over the age of 65 suffer falls every year, and around 80,000 break the neck of the femur, leading to serious after-effects and dependency. INDIENOV is an AI-enabled airbag belt that detects the movement of a lateral fall, triggers an airbag reducing the risk of femoral neck fractures … Type: Startup Activities: manufacturing healthtech Technologies: Synthetic Biology | 37 | 13 |
 | Diamidex Make Visible the Invisible Faster to Make your World Safer Founded in 2014, DIAMIDEX (Diagnostic Microbiology Express) is an innovative company specialized in the detection and quantification of microorganisms of interest. Its mission: making the invisible visible faster, to make your world safer. Its patented innovative technological approach brings about a major breakthrough to meet the speed and technicality challenges arising from microbiological culture. Based on a powerful technological platform, recognized by the scientific and industrial communities, DIAMIDEX offers and develops turnkey test solutions, which can be used in both laboratories and in the field to obtain a quantitative count … 64 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 18 | 31 |
 | ADDIDREAM ADDIDREAM is a french company dedicated to the medical additive manufacturing. Thanks to a 550 m2 production area of different medical adapted 3D printing technology, we offer innovate solutions for the healthcare industry. Our services include computing aided design (CAO), different types of biocompatible materials 3D printing, and post-treatment processes. 64 similar entities Type: Startup Activities: deeptech healthtech industry 4.0 manufacturing Technologies: 3D Printing Synthetic Biology | 6 | 13 |
 | Dyameo Dyameo is a research company & amp; Development in the field of medical devices which designs aid probes for the diagnosis of in-vivo cancer cells. This medical device, makes it possible to answer the question: "Are these cells cancerous?", And that in a simple, clear and instant manner. This rupture solution proposes to discriminate cancer cells at an early stage, during endoscopic examinations. Medical devices, medtech, and help with in-vivo cancer diantics 63 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 4 | 8 |
 | SeaBeLife Biotech Solutions to deprogram cell death : A breakthrough innovation to treat and prevent severe pathologies We develop small molecules that inhibit regulated necrosis using an original mechanism of action. Regulated necrosis is one of the recently identified pathophysiological factors in many diseases with severe outcomes. The technical, therapeutic and economic potential is major. Our activity focuses on the development of drugs inhibiting regulated necrosis, from the selection of the molecule to the proof of efficacy in the patient. We focus on acute and orphan diseases because preclinical and clinical development is facilitated, allowing proof of concept (POC) to be provided … 3 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 19 | 12 |
 | Perha Pharmaceuticals From Sea to Pharmacy Perha Pharmaceuticals is a biotech company identifying, optimizing and characterizing innovative, low molecular weight kinase inhibitors and developing them up to proof-of-concept in man. Perha Pharma focuses its research on two main diseases: cognitive disorders associated with Down syndrome (DS) and Alzheimer’s disease (AD), and hearing loss (HL) induced by ototoxic products. The first proof-of-concept in man should be achieved in both pathologies through niche indications: cognitive deficits in DS and hearing loss induced by cis-platin or aminoglycoside antibiotics. Perha Pharma was co-founded in April 2019 by Dr Laurent MEIJER, Chairman & CSO, former distinguished Director … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 12 |
 | Apmonia Therapeutics Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies. Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies. Our innovative technological approach is to target tumors overexpressing matricellular protein thrombospondin-1 (TSP-1). Our long-term vision is to develop personalized immunotherapy approaches combining a proprietary therapeutic peptide targeting TSP-1 (namely TAX2 peptide) and a companion diagnostic kit, which may enable patient stratification for TAX2 therapy eligibility based on the monitoring of circulating TSP-1. immunologie and oncologie 29 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 37 | 19 |
 | EVEON Transforming Patient Experience EVEON aims to become international leader in the automatic preparation and delivery of therapeutic treatments to improve patient quality of life. As a partner of healthcare players, EVEON designs and manufactures technological, digital and user innovation products and services. Forward looking, EVEON places at the heart of its commitments social values of high standards that meet the challenges of personalized and participative medicine. EVEON focuses on business partnerships with a collaborative spirit of transparency and openness. EVEON develops a strategy based on ethical values of performance and adaptability to the needs of its clients. Type: Startup Activities: healthtech manufacturing deeptech Technologies: Synthetic Biology | 15 | 16 |
 | NanoMedSyn NanoMedSyn develops a new delivery platform to create first-in-class drugs by the engineering with patented AMFA vectors NanoMedSyn was born from the fundamental research of its biologist and chemist founders who discovered a breakthrough technology for drug delivery to the lysosomal cell compartment leading to potentiation of therapeutics. This technology, validated at the preclinical level, has a wide range of applications in the fields of oncology, immunity, inflammation or metabolism. NanoMedSyn’s development plan is based on a strong intellectual property of patented synthetic derivatives called AMFA. The main application is the engineering of recombinant proteins like antibodies or enzymes for … 156 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 4 |
 | Continuum Plus Santé Reinvent monitoring of patients under anticancer #Akoadom, continuum+ Connect remote monitoring platform Closer to patients. Cancer, health, digital, e-health, home support, and Télésuivi 260 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology | 39 | 21 |
 | Aenitis Technologies Acoustic Cell Processing Solution 🚀 Aenitis designs, develops, and markets sole-in-class acoustofluidic technology that makes cell and gene therapy manufacturing better, safer, and less expensive. By precisely controlling levitated cells with sound waves, our systems handle cells in full sterile conditions and radically increase productivity while preserving the native state of cells at every step of the engineering process. This technology enables gentle, non-invasive manipulation of cells at the millifluidic scale, allowing for the handling of tens of milliliters per minute. Such capabilities are critical for scaling applications from research to clinical and industrial use. 💡Today, we have achieved proof-of-concepts … 19 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 31 | 17 |
 | Pharmao Home delivery of drugs and parapharmacy 7 days a week 🚲💊 With Pharmao no need to move, have you delivered in less than an hour, 7 days a week, your medication or your parapharmacy! Msanté, Clickandcollect, Drive, and Webtostore 51 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology | 7 | 4 |
 | BioAxial, part of Telight Explore the Unseen BioAxial is now part of Telight. Please follow our news at Telight LinkedIn page https://linkedin.com/company/telight TELIGHT specializes in a field of instruments employing light optics, in particular, providing innovative types and solutions for light microscopy. Super Resolution Microscopy, Fluorescence Microscopy, Conical Diffraction Optical Components, Nanoscopy, Living Cell Imaging, Low phototoxicity, Standard Workflow, Multicolor Imaging, and Intuitive 25 similar entities Type: Startup Activities: nanotech deeptech Technologies: Synthetic Biology | 4 | 24 |
 | Di&Care Power Your Health Di & amp; Care is a French company dedicated to the development and marketing of "digital drugs" in the field of sleep and mental health. Our treatments are based on reference therapies in the management of these diseases. Health, mental health, digital drugs, health professionals, sleep specialists, sleep, and doctors in pharmacy 61 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology | 6 | 3 |
 | MED'INN'Pharma A clinic-ready biotech developing human cell-derived secretome drugs to cure inflammation-related pathologies Med’Inn’Pharma (MIP) is a clinic-ready Biotech company that was founded in 2017 as a spin-off from the French blood bank establishment (EFS) and of the French National Institute of Health (INSERM). MIP is a pioneer in developing a new class disease modifying therapies dedicated to resolve pathologic inflammation in a wide range of degenerative diseases and conditions. Our founders are world leaders in immunology and inflammation-resolution, and have developed a patent protected process to harness bioactive molecules from physiologically conditioned human cells into a stable biologic drug product. … 5 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 3 |
 | Cellaven Cell culture automation, affordable and easy to use, for R&D labs. Cell culture automation for R&D labs: Affordable, time-saving and easy to use. The Nestor automaton is a plug-and-play device able to culture cells in up to 10 flasks or multiwell plates. It is ultra-compact and portable, with a 2xA4 sheet footprint and a weight below 5 kg. Automate the most time consuming tasks in your cell culture processes, for an investment in the range of any other basic lab equipment (and get a return on your investment within 24 months only). biotechnology, automated cell culture, and 3D cell culture 14 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 11 | 6 |
 | Kinathera develop first-in-class oral drugs for autoimmune diseases. Kinathera is a seed stage preclinical biotech on a mission to develop unique series of newly patented, orally delivered small chemical molecules to treat patients suffering from immuno-inflammatory disorders. Selective inhibition of our most advanced target, simultaneously: 1, blocks intracellular cascade of the ICOS receptor which control maturation of the humoral response and 2, inhibits type 1 interferon production, a master regulator of BAFF expression and demonstrated component of auto-immune diseases. Activity of Kinathera’s compound on two key immune paths promises enhanced control of hyperactive immune reaction in auto immune or GvHD indications. … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 3 |
 | Kapto Medical SAS Confident clot retrieval Introducing a clot adhering coating that is easily applied to medical devices to improve clot capture and retrieval. Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 0 | 2 |
 | OSE Immunotherapeutics Immuno-Oncology and Immuno-Inflammation - Breakthrough Immuno-Science for Patients OSE Immunotherapeutics, a biotech dedicated to developing first-in-class assets in immuno-oncology (IO) & immuno-inflammation (I&I). • Tedopi® (therapeutic cancer vaccine): Registration Phase 3 in 2nd-line NSCLC in HLA-A2+ patients with secondary resistance. Phase 2 trials, sponsored by onco groups, of Tedopi® in combo in solid tumors. • Lusvertikimab (mAb IL-7R antagonist); Positive Phase 2 in UC; preclinical research in ALL. • OSE-279 (anti-PD1): 1st positive results in Phase 1/2 in solid tumors. • FR-104/VEL-101 (anti-CD28 mAb): developed in partnership with Veloxis in transplant; Phase 1/2 in renal transplant (CHU Nantes); successful Phase … 60 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 26 | 1 |
 | AnyGenes® Since more than 10 years, AnyGenes® scientists develop and produce innovative high throughput screening products for signaling pathway analysis. These kits and reagents allow high throughput transcriptomic analysis of a large collection of signaling pathways in many species, biomarkers identification and validation, as well as validation of microarrays results. AnyGenes®, with its innovative & cost effective technologies, products and its proprietary molecular platform, helps scientists to accelerate their projects, publications, and biotech companies for drug development and biomarkers validation. Located in Paris, within Tenon Hospital in the 20th arrondissement, AnyGenes® constitutes a key player in the Biotechnology field. Supported by … 21 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 5 |
 | ANAQUANT Identify and quantify your Host cell proteins thanks to our HCP profiler solution! #TechnologicalCRO #HCP ANAQUANT provides pharmaceutical and biotech companies with high quality services in detection and quantification of proteins by mass spectrometry, in order to speed up their R&D. Thanks to its unique know-how in control and validation of protein quantification, ANAQUANT is a partner of choice for customized assay development of proteins. Our expertise in performing specific and sensitive assays – from one to several dozens of proteins in a small sample volume – significantly contributes to the success of discovery and validation of biomarkers. Our proprietary … 29 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 9 |
 | BIOPHYTIS - Live Healthier Longer Société de biotechnologie au stade clinique axée sur le développement de son principal candidat médicament, RUVEMBRI Biophytis SA is a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging. Our small molecules are aimed at stimulating biological resilience to stress during aging. Ruvembri - in regulatory and clinical phases - is our leading drug candidate is administered orally: • for the treatment of severe respiratory events related to COVID-19 following positive results in Phase 2/3 clinical study (COVA) • for the treatment of reduced mobility in elderly patients with … 62 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 24 |
 | kyron.bio Next generation bioproduction platform Kyron.bio is revolutionising the way we make our therapeutic drugs. Our novel engineering strategy allows us to precisely control the glycosylation pattern on the surface of a biologic in order to develop the next generation of medicines. This unique approach enables us to sculpt biologics based on the sugars that are attached to the surface, helping to make therapeutics safer and more effective. Our work at Kyron.Bio is opening up a new era of biologics engineering – one with the power to create positive health outcomes for patients whose needs are currently unserved by the pharmaceutical … 69 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 7 |
 | KCAS Bio - Lyon Science Accelerated KCAS Bio - Lyon (Active Biomarkers) operates as a bioanalytical laboratory based in Lyon, France and headquartered in Olathe, Kansas, USA. We offer comprehensive service solutions for the development of both large and small molecules, with extensive capabilities and expertise in pharmacokinetics, immunogenicity, soluble and cellular biomarker analysis for clinical trials. Operating in state-of-the-art BSL2 facilities, our company is GLP certified and ISO 9001:2015 certified, with a unique track-record in the development, validation, and implementation of analytical methods. Our expert team has supported hundreds of studies in multiple therapeutic areas: oncology, infectious diseases, inflammatory pathologies, and neurodegenerative diseases. … 57 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology Data Analytics | 2 | 31 |
 | MAG4HEALTH Affordable high-end neuroimaging We make and sell brain imaging systems showing neural activity called magnetoencephalographs (MEG). We democratize the use of MEG, using a space technology, to effectively detect brain defects and improve brain cares MEG, medical device, and functional imaging Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 8 | 21 |
 | AUROBAC THERAPEUTICS Tackling bacterial infections, antimicrobial resistance, and their consequences in acute care settings. AUROBAC THERAPEUTICS is a biopharmaceutical company founded in 2022 by three highly renowned life sciences innovation companies, Boehringer Ingelheim, Evotec and bioMérieux, to become a global leader in the fight against bacterial infections, Antimicrobial Resistance (AMR) and their consequences in acute hospital settings. AUROBAC’s R&D strategy addresses these unmet medical needs with patient- and pathogen-targeted programs designed to tackle both the causes and consequences of potentially life-threatening bacterial infections and AMR, including hospital-acquired and ventilator-associated bacterial pneumonia (HABP and VABP) and sepsis. 14 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 29 |
 | ORPHELIA Pharma Children with rare diseases deserve therapeutic answers ORPHELIA Pharma is a French pharmaceutical company based in Paris and Lyon that develops and markets medicines for the treatment of pediatric orphan diseases. ORPHELIA Pharma‘s mission is to provide patients with essential products in the fields of epilepsy and pediatric oncology, with formulations adapted to the pediatric population. With one drug approved in the European Union and one product in late-stage clinical development, ORPHELIA Pharma has recently established regional agreements in the European Union, the USA and China and conducts research projects through academic and industrial partnerships. Neurology, Pediatry, Orphan drug, and … 18 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 11 |
 | LabSkin Creations Your Skin Designer LabSkin Creations is a biotechnology company specializing in advanced 3D skin and adipose tissue engineering. By combining innovative cell culture techniques as well as proprietary technologies based on scaffolding biomaterials and 3D bioprinting approaches, LabSkin designs and creates unique and versatile 3D reconstructed models for the performance evaluation of skin and personal care products and their ingredients. tests d'activité et d'efficacité, analyse d'image, Histologie, Immunohistochimie, Biologie cutanée, 3D, Reconstructed skin, and Adipose Tissue 63 similar entities Type: Startup Activities: deeptech industry 4.0 Technologies: Synthetic Biology | 6 | 11 |
 | ADOCIA "Innovative medicine for everyone, everywhere" "Innovative medicine for everyone, everywhere" Listed on the Euronext stock market, Adocia is a clinical-stage biotech company specialized in the development of best-in-class medicine relying on innovative formulations of already-approved therapeutic proteins. Adocia is specialized in diabetes and obesity. The proprietary BioChaperone® technological platform is designed to enhance the effectiveness and safety of therapeutic proteins and their ease of use for patients. For more information, visit our website: www.adocia.com For careers offers, please click to the following link : https://www.adocia.com/careers/adocia-careers/ Therapeutic proteins, BioChaperone®, Next-generation injectables for diabetes treatment, Ultra-rapid Insulin, Multi-agents injectable combination, Diabetes, Metabolic … 59 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 9 | 93 |
 | Cellenion Experts in single cell isolation technology for sequencing and cell line development applications. Cellenion offers solutions and technologies for controlled cell dispensing with applications in the fields of single-cell isolation and bioprinting : Ability to manipulate single-cell has long been a challenge for the scientific community due to their micrometric size and delicate nature. Cellenion has developed and patented CellenONE, a breakthrough single cell isolation and dispensing technology. CellenONE provides outstanding single cell precision, high throughput, and unmatched recovery. Bioprinting is the process of generating spatially-controlled cell patterns using 3D printing technologies. Cellenion will aim toward both miniaturization and automation … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 26 |
 | Exeliom Biosciences Crossing the next frontier, to give you a fair chance to fight Exeliom Biosciences is a clinical-stage biotechnology company developing next-generation immunotherapies in immuno-oncology and immuno-inflammation. Our novel candidates harness microbiome-associated innate immune regulatory mechanisms. Inflammatory Bowel Diseases, Live Biotherapeutics, Microbiome, Immunotherapies, Immuno-oncology, and Immuno-inflammation 101 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 13 | 8 |
 | ANTINEO Antineo aims to accompany customers in the preclinical development of novel anticancer agents. We provide services and strategic advice for preclinical development, optimal choice of in vitro and in vivo models as well as strategic input on potential indications to target in the therapeutic landscape. Développement préclinique, in vitro, ex vivo, in vivo, Preuve de concept, Expertise scientifique en pharmacologie, and Modèles à façon 143 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 8 |
 | Kejako Keep your Eyes Young Our mission Kejako, in the field of ophthalmology, merge Medtech and Engineering expertise to develop solution for interested presbyopic patients seeking to keep quality of life through the compensation of visual accommodation decay. We address presbyopia with an anti-aging mindset to treat the gradual loss of visual accommodation. Our promise, unlike any other existing surgical solution, is to provide non-invasive (ultra-minimally invasive or a “no-cut”) laser solution to delay the need for reading glasses without compromising the patient’s quality of vision. Our solution will be fully personalized to the patient by using our simulation expertise which … 4 similar entities Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 6 | 3 |
 |  NETRI INNERVATE. SCREEN. PREDICT. NETRI is a technology enabling company that provides human cell based smart assays for high throughput preclinical data acquisition for the neurological Pharma & Cosmetics industries. We provide organs-on-chip solutions & interoperable in vitro models designed to deeply accelerate drug discovery and preclinical trials by mimicking in vivo neural connectivity. neuroscience, microfluidics, neural network, organ on chip, neurofluidics, neurological troubles, Alzheimer, Parkinson, organonchip, dermo-cosmetics, and toxicology 62 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 52 | 38 |
 | Fabentech Fabentech is a privately owned biopharmaceutical SME based in Lyon (France) and created in 2009, which develops immunotherapies to address situations of emergency. In an environment where the globalization of trade accelerates the spread of epidemics and where the geopolitical context increases the risk of bioterrorist attacks, nations should be prepared to address various situations of public health & medical emergency. However, there is generally no real therapeutic option to fight acute symptoms arising from these neglected indications. Based on its horse F(ab’)2 platform, a fully-derisked technology in-licensed from Sanofi Pasteur, Fab’entech aims to provide therapeutic solutions in the fields … 4 similar entities Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology | 20 | 62 |
 | FasTeesH Hesy, medical device for effective dental brushing in 10 seconds for care and accommodation establishments 📢📢📢The consumer product, Y-BRUSH, is available now: http://ow.ly/dmal30luqk 🚀🚀🚀 Fasseesh is a Lyon startup developing a "toothbrush of the future" which cleanses all the teeth simultaneously, simply and effectively, in only 10 seconds. For what ? Few people like to brush their teeth. This daily task is therefore often "badly" and/or "quickly" made. This can cause health problems, sometimes very serious. How ? Currently, we brush only 1 face of one tooth at a time. Our innovation makes it possible to brush 16 full teeth … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 2 | 1 |
 | HEMARINA Committed to saving lives. Hemarina is an innovative biotechnology company specializing in health product development based in Morlaix (29600, FR). Our search for new solutions based on the properties of the haemoglobin of the arenicola marina worm is permanent to improve the quality of life of patients and their families. Our commitment: to save lives by putting the patient at the heart of all our actions. BioTech, Ocean, Biomimicry, Biology, Biodiversity, and Transplantation 7 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology | 36 | 18 |
 | BioPharmAnalyses Biopharmalysis is an information site that allows you to make an active watch and follow the strategic developments of companies in the biopharmaceutical sector. With biopharmalysis: • You get a synthetic view of recent news from the sector • You are aware of the latest key agreements and mergers and acquisitions • You follow the clinical and regulatory progress of development products • You have access to the latest subsidies, fundraising and IPOs on the stock market Its five databases have more than 13,000 interactive sheets on agreements, clinical trials, fundraising, mergers/acquisitions and the regulatory life of biopharmaceutical products in … 31 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 16 | 2 |
 | PEPTINOV Peptinov is a biotechonology company based in Cochin Hospital (Paris, France) and founded by Prof. Jean-François Zagury to develop innovative peptide-based immunotherapies to treat chronic inflammatory diseases. Peptinov’s strategy is to induce the production of antibodies targeting self-proteins directly by the organism of the patient, through immunizations against carefully selected, highly immunogenic peptide sequences. Peptinov’s high potential R&D platform uses the tools of bioinformatics and molecular modelling to design these peptide sequences. This platform is potentially applicable to any crystallized protein and can quickly generate peptide candidates. Peptinov’s value proposition is built on its unique capability to develop anti-self proteins … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 16 |
 | Depixus Depixus SAS, based in Paris, is a life science technology company pioneering a groundbreaking technology based on magnetic force spectroscopy. This innovative technology provides real-time analysis of individual biomolecular interactions at scale, enabling researchers to decode disease mechanisms and unlock faster routes to more effective therapies. Single molecule analysis, RNA Drug Discovery, Protein-protein Interaction Analysis, Biophysics, Drug Discovery, Compound Screening, biomolecular interactions, and interactomics 159 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 57 |
 | CorWave CorWave develops and manufactures innovative implantable blood pumps based on a breakthrough membrane technology. CorWave is a French company developing innovative cardiac assist devices. CorWave’s wave membrane pump is a breakthrough technology that differs from today’s commercially available left ventricular assist devices (LVADs) by its physiological operation, designed to mimic a pulse and blood flow rates similar to those of a healthy heart. Ultimately, CorWave’s membrane pump technology is expected to reduce the complications associated with current devices and improve the management of heart failure patients. A member of the French Tech 120, CorWave was founded in 2012 by start-up … Tags: FrenchTech120 Type: Startup Activities: deeptech healthtech manufacturing nanotech Technologies: Synthetic Biology | 34 | 96 |
 | NEURON EXPERTS Neuron Experts is a Contract Research Organization (CRO) specialized in the study of neuro-active compounds. The company uses its own tests based on primary neuronal cell cultures modeling neurodegenerative diseases. With 120m2 of independent laboratory into the North Faculty of Medicine of Marseille in France, Neuron Experts is benefiting from numerous facilities and massively invested in high-tech equipment to provide the best service to clients. 30 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 9 |
 | CELLOMET CELLOMET provides cutting-edge R&D services on cellular metabolism for needs in industry and public institutions. CELLOMET is a spin-off CRO composed of internationally recognized experts in the field of cellular metabolism. Metabolism comprises crucial biological processes which enable breakdown of sugars, proteins, and lipids necessary to provide life-sustaining energy in all types of living organisms. CELLOMET has developed in-depth knowledge and cutting-edge technologies to address any particular metabolic modification occuring at the cellular level. This expertise can be applied to study the effects of pharmacological compounds or natural extracts in cosmetology, the impact of genetic modifications or nutrition, and the … Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 3 | 4 |
 | Kolibri Playing music to cells Kolibri revolutionises the way we grow and engineer cells at scale using acoustic waves. 🔍 Book a discovery call: https://calendly.com/tamsin_kolibrilab/discovery-call Showing 10x increase in cell density and 50x reduction in production costs, our patented bioreactors help our partners in drug development unlock patient access to gene therapies, with a proof of principle in AAV gene therapy. Being cell-agnostic and scalable, our process has significant potential across a range of high-value cell-based therapies - or in the cellular agriculture space more broadly. gene therapy, biomanufacturing, cellculture, acoustics, hardtech, and biotech 137 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 14 | 13 |
 | Carroucell Experts in industrial bioprocess optimization | Scalable microcarrier tech for advanced cell culture. 🔬 Industrial Bioprocess Optimization Experts | Enabling Scalable & Controlled Cell Manufacturing 🚀 At Carroucell, our expertise is built on years of dedicated R&D and strategic partnerships with leading cell producers 🤝. We have developed a groundbreaking microcarrier specifically designed for static environments, and our extensive experience supports the entire bioproduction chain—from initial project design to full-scale industrial manufacturing 🏭. Our flagship platform, FlexiGrow, is engineered using advanced sol-gel processes and bioinert glass. This technology not only delivers optimal cell adhesion, viability, and recovery but also sets … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 2 | 5 |
 | Quantum Genomics The objective of Quantum Genomics is to become a leading actor in the treatment of cardio-vascular diseases through the development of a new therapeutic class: BAPAIs for BrainAminopeptidase A Inhibitors. We wish to develop and provide effective and well tolerated therapeutic treatments for controlling high blood pressure and to for preventing related cardio-vascular risks such as heart failure. High blood pressure remains a major public health concern. Quantum Genomics is the only biopharmaceutical research company developing new therapies from a real breakthrough innovation based on the inhibition of brain Aminopeptidase A. The mid-term strategic objective of the company is to … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 4 |
 | Luxia Scientific New generation microbiome diagnostics for personalised medicine Luxia Scientific is a french start-up company, leading the next wave of breakthrough personalized diagnostics. The company was started by Alessandra Cervino, former research director at Enterome. Luxia scientific is pioneering the development of novel diagnostics based on the genetic analysis of microbiomes. The company has brought to the market it’s first test in Q4 2018 and is developing two additional diagnostics. The Company is affiliated to Medicen and is supported by the BPI, Region Ile de France. Statistics, Biomarkers, Statistical genetics, qPCR, genetics, genomics, microbiome, metagenomics, nutrition, well being, health, probiotics, prebiotics, … 60 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Data Analytics Synthetic Biology | 4 | 1 |
 | Fizimed A powerful way to women's healthcare A pioneer in FemTech and HealthCare, Fizimed develops innovative, connected medical devices that make it easy to take control of your health at home. women health, urinary incontinence, breastfeeding, prolapse, perineal reeducation, and post partum 60 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology | 31 | 24 |
 | Neuroservice In vitro Slice Electrophysiology for CNS and Pain Research Neuroservice USA has been acquired by Neuroservices Alliance Please visit: https://www.linkedin.com/company/18799325 Drug Discovery, CNS, Electrophysiology, Pharmacology, Multi-Electrode Array, Patch-Clamp, Pain, Brain slices recordings, Safety, Toxicology, Neuropharmacology, CNS Research, CNS Preclinical Research, Preclinical Research, and CNS Electrophysiology 46 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 4 |
 | AQEMIA Scale Drug Discovery with Quantum-inspired Physics and AI AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology. Our unique approach leverages quantum-inspired physics algorithms to power generative AI in designing novel drug candidates—without relying on experimental data. We already delivered several drug discovery successes within our internal pipeline and through collaborations with pharmaceutical companies. Our most advanced programs are currently in vivo optimization. AQEMIA is based in Paris and London. We are growing and hiring! Check our … 32 similar entities Tags: FrenchTech120 FrenchTech2030 Type: Startup Activities: deeptech healthtech Technologies: A.I. Generative A.I. Synthetic Biology | 69 | 75 |
 | SMARTOX Smartox Biotechnology is specialized in peptide research and manufacturing Smartox Biotechnology is specialized in peptide research and engineering. Peptide synthesis, physiology, pharmacology, neuroscience, ion channel research, toxin, venomous animals, and screening library 336 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 0 | 8 |
 | dianosic "Smartly designed for you" Dianosic ambitions to become a leading company in solving challenges in patient’s adherence to medication. We provide an alternative to daily medication by designing a unique sustained intranasal drug delivery solution for respiratory and chronic central nervous system diseases. Dianosic aims to fight against debilitating chronic diseases that affect millions of people. Our first focus is on chronic allergic rhinitis and chronic rhinosinusitis. Currently, 85% of allergic rhinitis patients are not compliant with their treatment. Furthermore, 20% to 25% of patients do not respond to first-line treatments. These medical challenges significantly impact patient’s quality of life. … Type: Startup Activities: deeptech Technologies: Synthetic Biology | 27 | 13 |
 | Vibiosphen From Microbes to One Health. Taylor made R&D to tackle infectious diseases. Vibiosphen is a SME healthcare biotechnology in infectious diseases founded in 2014. Given the important and interdependent human, animal, and environmental dimensions of antimicrobial resistance, the One Health concept promotes a global effort to achieve the best health for people, animals, and the environment. In this context, Vibiosphen takes part of the efforts that are underway to develop new anti-infective therapies, to rejuvenate the antibiotic pipeline, develop novel antibiotics, and discover innovative therapeutic strategies for priority pathogens. Based on its pluridisciplinary and integrated approaches, Vibiosphen, with more than … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 5 | 6 |
 | USC The official Twitter account of the University of Southern California. #USC | #FightOn Type: SMB Activities: deeptech Technologies: Synthetic Biology | 53 | N/A |
 | UE LifeSciences Making the hope of early detection, a reality. Meet the team behind iBreastExam and cervAIcal! UE LifeSciences is a fast-growing, multi-national med-tech company bringing the promise of early detection of cancer to women globally. Our innovations have reached more than 250,000 women in 12 countries. We've grown revenue five-fold in the past three years with distribution in 10 countries and counting. And we've raised over $6 million in grants, international awards and equity capital! Our work is featured on platforms such as TED Talks and notable publications such as The New York Times, BBC World News, Forbes and others. Medical … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 10 | 62 |
 |  OvaScience OvaScience, Inc. (NASDAQ:OVAS) is a company focused on the discovery and development of new treatment options for women and families struggling with infertility. Each OvaScience treatment is based on the Company’s proprietary technology platform that leverages the breakthrough discovery of EggPC cells – immature egg cells found within the outer ovarian cortex. OvaScience is developing OvaPrime, a potential fertility treatment that could help restore a woman’s egg production, and OvaTure, a potential fertility treatment that eliminates the need for hormone stimulation. OvaScience’s AUGMENT treatment, designed to improve fertilization and pregnancy rates, is available in Japan under an exclusive license to … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 8 |
 | SimpleTherapy Personalized, clinically-based virtual and in-person solutions for total well-being. SimpleTherapy provides physical, MSK, and behavioral health services that combine digital and technology-guided treatment with a national network of in-person and telehealth providers. At our core is a commitment to providing inclusive, holistic care that is simple, accessible, and personalized. Our clinically backed, innovative solutions support the overall health of your workforce and reduce costs for all parties. Our clients include employers of all sizes, major health plans, and Fortune 50 organizations. SimpleTherapy, where improved health meets simplicity. Notable Media Coverage: - The New York Times: http://nyti.ms/1ivhBZC - The Huffington Post: … 7 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology | 1 | 30 |
 | InquisitHealth is now Pyx Health Delivering better health 1-1 via an empathy-first Peer workforce Health plans, health systems, and employers leverage our Peer workforce (tech-enabled remote workforce of community health workers) to engage struggling patients (with empathy!) and help them address SDoH barriers, activate healthy behaviors and improve clinical outcomes. peer support, peer mentoring, community health workers, diabetes, asthma, prediabetes, sickle cell, hypertension, digital health, and coaching 86 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 1 | 37 |
 | Synthorx Inc Synthorx, Inc. is a biotechnology company focused on prolonging and improving the lives of people with cancer and autoimmune disorders. Synthorx’s proprietary, first-of-its-kind Expanded Genetic Alphabet platform technology expands the genetic code by adding a new DNA base pair and is designed to create optimized biologics, referred to as Synthorins. A Synthorin is a protein optimized through incorporation of novel amino acids encoded by the new DNA base pair that enables site-specific modifications, which enhance the pharmacological properties of these therapeutics. The company’s lead product candidate, THOR-707, a variant of IL-2, is in development in multiple tumor types as a … 26 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 5 |
 | RxGenomix Making personalized healthcare possible for individuals, healthcare providers, benefit administrators and employers. Pharmacogenomics (PGx) is the next frontier in medication therapy management and RxGenomix was created specifically to help put it to work for everyone. RxGenomix helps healthcare providers understand the genetic-driven mechanisms behind the response to medications and navigate the implementation process of a new healthcare tool. By applying PGx testing, they can look at very specific pieces of their patients’ DNA to know, for many of the most common and critical medications, precisely which might be best for that individual, and at what dosage. Empowering healthcare providers with … 4 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology | 2 | 11 |
 | Portal Instruments Connected, Reusable Drug Delivery Portal Instruments is a Series C funded medical device company focused on advanced drug delivery and backed by strategic and venture investors. We are developing and commercializing a highly innovative needle-free drug delivery platform technology to transform the administration of medicines and improve the patient experience for those with chronic disease who inject themselves. Portal’s needle-free delivery technology is derived from research at MIT and enables the administration of high viscosity biologic drugs with less discomfort and without the anxiety of handling needles. Using precise pressure technology, the injection is administered through the skin via a … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 2 | 25 |
 | REGENXBIO Seeking to improve lives through the curative potential of gene therapy. REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development of AAV Therapeutics, an innovative class of gene therapy medicines. REGENXBIO is advancing a pipeline of AAV Therapeutics for retinal and rare diseases, including ABBV-RGX-314 for the treatment of wet AMD and diabetic retinopathy, being developed in collaboration with AbbVie, RGX-202 for the treatment of Duchenne and RGX-121 for the treatment of MPS II. Thousands of patients have been treated with … 14 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology SaaS | 1 | 379 |
 | Sage Therapeutics Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and change how brain disorders are thought about and treated. Our mission is to pioneer solutions with the potential to deliver life-changing brain health medicines, so every person can thrive. Welcome To The Workplace With A Difference At Sage, we believe that life is more … Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 9 | 486 |
 | Aimmune Therapeutics POWER OVER FOOD ALLERGIES Aimmune Therapeutics, Inc., a Nestlé Health Science Company, is a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies. With a mission to improve the lives of people with food allergies, Aimmune is developing and commercializing oral treatments for potentially life-threatening food allergies. The Company’s Characterized Oral Desensitization ImmunoTherapy (CODITTM) approach is intended to provide meaningful levels of protection against allergic reactions resulting from accidental exposure to food allergens by desensitizing patients with defined, precise amounts of key allergens. Aimmune has one FDA-approved medicine for peanut allergy and other investigational therapies in development to … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 88 |
 | Prapela The first and only FDA-authorized treatment for opioid exposed newborns with neonatal opioid withdrawal syndrome (NOWS). Prapela is a breakthrough noninvasive stimulation therapy that naturally improves breathing and oxygenation in newborns. Based on a field of science called Stochastic Resonance, our precise and gentle stimulation improves breathing rhythm and lung function in newborns. Since 2017, we've received over $8M in awards and grants funding the clinical evaluation of our therapy to improve the treatment of opioid-exposed newborns and preterm infants with apnea of prematurity. Next, we aim to improve the treatment of preterm intermittent hypoxemia and bronchopulmonary dysplasia. For more … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 3 |
 | Recursion Decoding Biology to Radically Improve Lives Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one … 67 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology | 26 | 972 |
 | Laser Biotech International Superpulsed therapeutic lasers: Lumix 2 Series, Superpulsed + CW therapeutic lasers: Lumix 3 Series, Superpulsed + CW therapeutic lasers: Lumix 4 Series, Lumix Lasers, drug free pain relief, pain relief, laser therapy, alternative medicine, Chiropractic, dentistry, physical therapy, pain management, superpulsed lasers, therapeutic lasers, sports medicine, medical devices, and technology 93 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 0 | 3 |
 | Verastem Oncology Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with RAS/MAPK pathway-driven cancers. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition, FAK inhibition and KRAS G12D inhibition. Pursuing unexplored pathways demands that we’re purposeful in everything we do. And it’s an endeavor that’s only possible with an experienced team of employees and partners dedicated to a singular purpose: changing and improving the way cancer … 19 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 125 |
 | Lygos Better materials for better products Lygos is a pioneering sustainable specialty chemicals company, leading the world’s transition toward better, cleaner, and more sustainable products. We have built a proprietary and fully integrated platform of the most advanced technologies across synthetic biology, industrial chemistry, and application development to rapidly deliver market relevant solutions to some of the world’s biggest sustainability challenges. With a pipeline of high-performing, innovative solutions, Lygos is paving the way for generations of new sustainable solutions for our world. Synthetic Biology and Specialty Chemicals 66 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 73 |
 | Newel Health Beautifully designed and clinically validated digital medicine and digital therapeutics (DTx) solutions Newel Health represents a novel category of innovative companies whose mission is to develop and commercialize beautifully designed and clinically validated digital medicine and digital therapeutics (DTx) solutions in partnership with pharmaceutical and medical device companies and other health and wellness stakeholders. Built on a strong heritage in health innovation Newel Health leverages data and technology to future-proof healthcare, while putting human empathy and patients’ and HCPs’ actual needs at the center of all its products. 64 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology | 1 | 14 |
 | SynBiotic SE Making cannabinoids accessible What our ancestors instinctively knew and through centuries -old traditions also proves more and more scientific research: the active ingredients of the Cannabis sativa plant, the so -called cannabinoids, show many positive effects in use for medical purposes, such as chronic pain and epilepsy. But also in the area of cosmetics and the nutritional supplements, ingredients of the cannabis sativa plant are increasingly used. Synbiotic se pursues the goal of mapping the entire value chain of the cannabis sativa plant for the benefit of the people: from basic research to the synthetic production of these substances to … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 0 | 4 |
 | Elixirgen Scientific Transform how you model human biology. Elixirgen Scientific is a global leader in regenerative medicine and biotechnology, headquartered in the Science + Technology Park at the Johns Hopkins Medical Campus in Baltimore, MD. Our mission is to advance science and medicine with fast, functional, and scalable induced pluripotent stem cell (iPSC) differentiation products and services. Our state-of-the-art, transcription-factor-based technology allows you to overcome the high cost and inefficiencies associated with lengthy cell differentiation periods. We empower research institutions, pharmaceutical organizations, and biomedical enterprises worldwide, even those with no previous iPSC experience, by increasing access to relevant cells for modeling human … 75 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 21 |
 | MyoKardia Driven by the heart We officially combined with Bristol Myers Squibb to further strengthen our scientific capabilities and treatments for cardiovascular patients. Visit www.bms.com to learn more about our work to produce the next generation of medicines for patients with serious cardiovascular disease. For more information on the acquisition, see our press release at: https://one.bms.com/40FsT7W Genetic Heart Disease, Cardiomyopathy, biotechnology, cardiovascular disease, heart failure, precision medicine, therapeutics, drug discovery, drug development, and R&D Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 1 | 32 |
 | Geltor Geltor is the biodesign company powering the products of the future with effective, sustainable, animal-free proteins Geltor is the biodesign company that audaciously imagines and deeply explores all the possibilities that the tree of life has to offer. With customer benefit at the fore of each step of the creative process, Geltor has created the largest selection of designer proteins that are crafted with unparalleled biocompatibility and functionality. These proteins are 100% animal- and GMO-free, globally scalable, and sustainably cultivated. Geltor’s products are the result of endless curiosity and ceaseless optimization, clinically demonstrated for high performance. Biotechnology, Protein, Cosmetics, Personal … Type: Startup Activities: deeptech fashtech biotech healthtech Technologies: Synthetic Biology | 4 | 17 |
 | DIANA Biotechnologies DIANA Biotechnologies: Diversified Biotech We are leading Czech biotechnology company with a great innovative potential. We focus on the development of products based on our cutting edge research in the fields of molecular diagnostics and drug discovery. We have global ambitions and since our foundation in 2018 we already have achieved some of our goals. During COVID-19 pandemics, we were able to quickly develop one of the most innovative COVID-19 tests worldwide and we helped to increase the testing capacity of the whole country. As a result, we became the biggest Czech manufacturer of RT-PCR tests. Besides RT-PCR, we continue … 59 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 3 | 48 |
 | iThylo iThylo supports companies on all alcohol issues : prevention, screening, follow-up iThylo is the first connected ethylotest. For professionals, it allows companies to ensure that their employees are able to work in the best possible conditions. The iThylo team's mission is to manage risks in companies. To contact us hello@ithylo.com Informatique, Objets connectés, Securité, Prévention, Pilotage des risques, Ethylotest connecté, Accompagnement, medtech, Dispositifs Médicaux connectés, dépistage, alcool, alcohol, drogue, and drug Type: Startup Activities: healthtech Technologies: Synthetic Biology | 7 | 25 |
 | ADEXSOL Adexsol is a consulting and training company based in Paris that provides healthcare companies and institutions with knowledge of the goals, organisation and functioning of the French healthcare system. Adexsol can help you with: - Better understanding and analysing needs of the hospital and healthcare world in order to build an offer meeting key players’ needs. - Setting up training for industry sales forces and managers on topics related to organisation and functioning of the hospital. - Carrying out market research, polls and opinion trackers. - Organising events nationally or regionally: conferences, workshops, seminars, and scientific boards. - Developing your … Type: Startup Activities: healthtech martech Technologies: Synthetic Biology | 5 | 2 |
 | Biomeca® Creator of solutions *A deep expertise in Biomechanics and Surface Analysis in Life Science* Living systems has to be considered as physical systems so that unravelling the physical mechanisms involved in complex biological processes and diseases is one of the main challenges of biology. In BioMeca we believe that the starting point is to give a quantitative physical description of biological samples to have a better understanding of such processes. BioMeca® is a company based in Lyon expert in biomechanics and mechanobiology and specialized in high-resolution structural and mechanical characterization of biological samples at different scales, from large structures, such … 27 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 8 |
 | ENTEROSYS - Gut Is The Link Preclinical studies in gut and gut brain for therapies of tomorrow 🔬 About ENTEROSYS At ENTEROSYS, we are science enthusiasts 🧪 driven by a conviction deeply rooted in medical history: for over two millennia, it has been acknowledged that the key to understanding many diseases lies in our digestive system and its interactions with other organs. Based on this ancient wisdom, we have embraced a modern and holistic approach focused on digestive physiology and the communication between the gut and peripheral organs. Specializing in the preclinical evaluation of compounds with therapeutic potential 💊, we utilize cutting-edge techniques to analyze physiological … 5 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 7 |
 | EOVE Inovative company specialized in the development and manufacture of medical devices EOVE develops and manufactures innovatives products to improve care and quality life with greater freedom for Adult ans Pediatric Patients who suffer from breathing disorders and chronic respiratory diseases. 219 similar entities Type: Startup Activities: healthtech manufacturing deeptech Technologies: Synthetic Biology | 3 | 34 |
 | IPRASENSE Cell Culture Monitoring Instruments IPRASENSE revolutionizes cell analysis with innovative technologies for automated cell counting and real-time visualization, ideal for research and quality control. Cell culture monitoring, Lensless Lensfree Imaging, Video microscopy, Time lapse Imaging, Automatic cell count and viability analysis, High throughput cell, Inside your incubator, cell count, cell counting, cell viability, cell viability analysis , cell monitoring, and angiogenesis 103 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 5 |
 | SC MEDICA Back pain. Instability. Complementary fixation. ▶️ Think Facets. SC MEDICA is the global leader in spinal lumbar facet fixation, dedicated to providing innovative solutions for back pain control and minimally invasive spinal fusion. Our mission: Raise awareness about the role of facet joints in a large number of spinal conditions. Make FFX® fusion a gold standard. Worldwide. Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 3 | 8 |
 | SkinDermic Clinical stage biotech company with innovative first-in-class new treatments in virology and dermatology SkinDermic® is a drug discovery company focused on developing breakthrough and innovative small molecule drugs for the treatment of HHV8 virus linked neoplasia and inflammatory skin diseases. SkinDermic® recently completed proof of concept clinical phase in humans with its First-in-Class treatments for acne and HHV8 associated diseases (Kaposi Sarcoma and Lymphomas). Skindermic owns now a pipeline with very active and very well tolerated new drugs for HHV8 associated diseases and acne vulgaris. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 5 |
 | The Twinkle Factory Twinkling reagents for in vivo protein studies: FAST, splitFAST, CATCHFIRE The Twinkle Factory offers exclusive twinkling reagents for life science research: flurogenic ligands for FAST and split FAST, protein fluorescent reporters, and fluorogenic molecular glues for CATCHFIRE, a self reporting protein dimerizer. Protein-protein interactions, high content analysis, anaerobe metabolic engineering, are our users keywords. The Twinkle Factory is dedicated to speed-up the dissemination of breakthrough fluorescent technologies across the life sciences community. molecular glues, protein-protein interactions, and fluorescent proteins 8 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology | 0 | 7 |
 | Adjuvatis Built around safe-by-design concept, Adjuvatis is committed for innovative formulations to improve pharmaceuticals Adjuvatis, a French startup in biotechnology, develops innovative safe-by-design delivery systems to help laboratories and pharmaceutical companies in vaccine formulation as adjuvants and in drug delivery as vectors for oncology, dermatology, infections, etc. Our first technology, called i-Particles®, is based on 200 nm-diameter particles composed of poly-lactic acid only (any surfactant and solvents) for formulation of hydrophobic molecules in the particle core and surface functionalization of peptides. Our second technology, i-LipoP®, consists in i-Particles® covered by lipidic bilayers at their surface for vectorization of nucleic acids and … 46 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 4 |
 | 3Biotech 3Biotech provides Innovative solutions continuously to create a new future and impact patient outcomes 3Biotech provides Innovative solutions continuously to challenge, support and accelerate the manufacturing of safe drug candidates. We are your colleagues, partner for the Chemistry, Manufacturing and Control (CMC) to succeed in your project and mission to create a new future and impact patient outcomes. Our Three Pillars are: 1.Safety 2. Efficacy 3. Manufacturing These are our drivers to secure all steps from the research to the first in human stage with the most innovative project strategy and plan of execution. We have implemented a human and … 68 similar entities Type: NGO, Think-tanks, Ed, & Culture Startup Activities: biotech deeptech fintech manufacturing regtech Technologies: Synthetic Biology | 2 | 4 |
 | BIOMILLENIA Microbiology assays at previously impossible speeds and strain banks with amazing diversity ! Microbiology is what we do. Our unrelenting focus has enabled us to develop unique capabilities in ultra-high-throughput single-cell culture of microorganisms. Businesses in areas as diverse as pharma, agriculture, food, human health and environmental protection have partnered with us to gain powerful competitive advantages from our technology.So could yours. Our proprietary microfluidic platform is capable of : - identifying microbes of interest based on their functional characteristics among millions of candidates - perform a wide range of assays at previously impossible speeds - generate strain banks with … 90 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 3 |
 | SynHelix (now Quantoom Biosciences, a Univercells Company) Large-scale DNA synthesis technology that harnesses natural enzymes. Since January 2022, SynHelix is part of Quantoom Biosciences. Please go to the Quantoom Biosciences Linkedin page or www.quantoom.com for more information. Molecular biology, synthetic biology, biotechnology, Biochemistry, Surface chemistry, lifesciences, computational biology, gene synthesis, gene therapy, cell therapy, bioeconomy, enzymology, Biocatalysis, Bioengineering, Enzyme engineering, Biotherapeutics, Protein engineering, Recombinant proteins, and nanotechnology 93 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 3 |
 | OxiProteomics Innovative scientific services on efficacy testing for bioactives or formulated products to support healthy aging. OxiProteomics is a technology-based start-up committed to promoting the healthy living and healthy aging of human population. We deliver proven science services to dermo-cosmetic and food industries to support marketing claims. We also offer environmental quality bio-monitoring solutions to promote sustainable development. OxiProteomics patented technologies are based on the direct and specific detection of functional high quality proteins vs. oxidatively damaged (carbonylated) in biological samples, with a remarkably specificity and sensitivity. We can detect and quantify for the first time, the quality of thousands proteins … 14 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 16 |
 | G.CLIPS biotech ENABLING TECHNOLOGY FOR THERAPEUTICS TARGETING MEMBRANE PROTEINS G.CLIPS biotech created the first enabling technology to unravel the potential of drug and antibody candidates on pathology-like format membrane proteins to be used in screening efforts, characterization, structural studies, mechanism of action, pharmacological profiling and target validation. We offer a unique technology to express, stabilize, select and validate membrane proteins as targets based on proprietary G.Screen® Platform. G.Mixes® G.Select® Assay G.Lipidomics® G.Validation® Assay We provide tailor-made services to pharma, biotech and animal health companies targeting membrane proteins (GPCRS, Receptors, Transmebrane Proteins) that would like to ascertain the necessary environment and conformation stabilization … 12 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 14 | 8 |
 | CLARTEIS Clarteis is a global specialist in the miniaturization and manufacture of medical devices dedicated to dermatology. CLARTEIS is a global leader in manufacturing advanced and innovative technologies for the Dermatological market. CLARTEIS team is specialized in developing miniaturized and high quality light-based medical devices to provide to Dermatologists worldwide. Type: Startup Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology | 2 | 11 |
 | AnatomikModeling 3D custom made implants AnatomikModeling creates 3D custom-made implants for Reconstructive&Aesthetic Surgery, Pneumology and Maxillofacial Surgery. Our 3D custom-made implants are designed for Pectus Excavatum, Poland Syndrome and others anatomy defects like hard or soft tissues loss. Medical Devices, Reconstructive surgery, Pectus Excavatum surgery, Poland Syndrome surgery, and 3D CAD CAM Medical implants 12 similar entities Type: Startup Activities: manufacturing healthtech Technologies: Synthetic Biology | 0 | 4 |